You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -9.4% | 21.2% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | 17.1 | 0.0 |
PEG | 0.0 | 0.2 |
Price / Revenue | 3.2 | 2.0 |
Price / Book value | 56.5 |
Latest | Forecast | |
---|---|---|
Revenue | 13.9% | 32.9% |
PBT | 0.0% | n/a |
EPS | 535.4% | 617.1% |
DPS | n/a | 0.0% |
Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 1,005.00 | 278.00 | $1.85 | 3.9 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 785.00 | 180.00 | $1.20 | 2.2 | -0.1 | -35% | n/a | 0.0% |
2020-12-31 | 647.00 | -173.00 | $0.40 | 18.6 | -0.3 | -67% | n/a | 0.0% |
2021-12-31 | 791.00 | 190.00 | $0.19 | 90.5 | -1.7 | -52% | n/a | 0.0% |
2022-12-31 | 901.00 | -95.00 | $1.22 | 18.4 | 0.0 | 535% | n/a | 0.0% |
Indivior reaches settlement in litigation with US states Sharecast News | 05 Jun |
---|---|
Indivior's opioid addiction sprat approved by FDA Sharecast News | 23 May |
Indivior lifts revenue guidance, cuts profit outlook after Opiant deal Sharecast News | 27 Apr |
Indivior settles antitrust MDL with states and DC | 02-Jun-23 23:59 |
---|---|
Total Voting Rights | 01-Jun-23 17:54 |
Holding(s) in Company | 26-May-23 23:58 |
Indivior to Participate in Upcoming Conferences | 25-May-23 23:58 |
Holding(s) in Company | 24-May-23 23:59 |